KWA
BCLI

Kingswood Wealth Advisors’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Kingswood Wealth Advisors’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,403
Closed -$45.8K – 662
2024
Q1 		$45.8K Buy
+5,403
New +$45.8K 0.01% 609
2023
Q3 		– Sell
-1,107
Closed -$34.2K – 425
2023
Q2 		$34.2K Buy
+1,107
New +$34.2K 0.01% 265